28%
of surveyed professionals believe current support solutions reach enough patients
Patient support is ready for its next evolution
Four short films, fresh new perspectives.
- Who we asked
- 100 pharmaceutical, biotech, and life sciences leaders responsible for patient support strategy, commercialization, market access, and vendor evaluation.
52%
say legacy solutions are too slow to innovate
50%
agree that emerging vendors are pushing the industry forward
.png?length=1920)
81%
of respondents recognize that consumers expect better experiences from pharmaceutical companies
70%
identified the period before or during months 1–3 as a major point of patient drop-off
The full report
Shattering the Patient Support Status Quo
How a new patient-centric model increases engagement and sustains adherence, with every finding in full.